New drug tested to halt kidney damage in lupus patients
NCT ID NCT05810948
Summary
This study tested whether adding an intravenous drug called efgartigimod to standard treatment could better control lupus nephritis, a serious kidney complication of lupus. It involved 73 Chinese adults with active kidney inflammation from lupus. The main goal was to see if the drug reduced protein in the urine and improved kidney response over 24 weeks of treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUPUS NEPHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Affiliated Hospital of Jining Medical University
Jining, China
-
First Affiliated Hospital of University of South China
Hengyang, China
-
Fujian Medical University Union Hospital
Fujian, China
-
Guangdong Provincial People's Hospital
Guangzhou, China
-
Henan Provincial People's Hospital
Zhengzhou, China
-
Huashan Hospital Fudan University
Shanghai, China
-
Hunan Provincial People's Hospital
Changsha, China
-
Jiangsu Province Hospital
Nanjing, China
-
Jiangxi Provincial People's Hospital
Nanchang, 330006, China
-
Jieyang People's Hospital
Jieyang, 522091, China
-
Liu Zhou Works Hospital
Liuchow, China
-
Peking University People's Hospital
Beijing, China
-
Peking University Third Hospital
Beijing, 100191, China
-
Renmin Hospital of Wuhan University
Wuhan, China
-
Shaanxi Provincial Hospital of Chinese Medicine
Xi'an, China
-
Shandong Provincial Hospital Affiliated to Shandong First Medical University
Jinan, China
-
ShengJing Hospital of China Medical University
Shenyang, China
-
Shenzhen People's Hospital
Shenzhen, China
-
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Guangzhou, China
-
The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University
Huainan, China
-
The First Affiliated Hospital of Nanchang University
Nanchang, China
-
The First Affiliated Hospital of Xiamen University
Xiamen, China
-
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, 310058, China
-
The First Affiliated Hospital, Zhejiang University
Hangzhou, China
-
The First Affiliated Hospital,Sun Yat-sen University
Guanzhou, China
-
The First Hospital of Hebei Medical University
Shijia Zhuang, China
-
The People's Hospital of Guangxi Zhuang Autonomous Region
Nanning, China
-
The Second Affiliated Hospital of Chongqing Medical University
Chongqing, China
-
The Second Hospital of Tianjin Medical University
Tianjin, China
-
Wuxi People's Hospital
Wuxi, China
-
Zhongda Hospital Southeast University
Nanjing, China
Conditions
Explore the condition pages connected to this study.